Oramorph (Morphine Sulfate)

Morphine Sulfate, the active ingredient in Oramorph, is an opioid analgesic presented as a strength/form for oral use. It is used to treat moderate to severe pain in adult patients when other analgesics are insufficient. GNH USA supplies Oramorph as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Oramorph as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Oramorph is an opioid analgesic that acts within the central nervous system to manage pain.

- Acute postoperative pain: provides rapid relief of pain following surgical procedures. - Cancer‑related pain: helps control persistent pain associated with malignant disease. - Severe chronic pain: used when other analgesics fail to provide adequate relief.

Adverse reactions to morphine may vary in frequency and severity.

Common Side Effects: - Constipation: reduced gastrointestinal motility. - Nausea and vomiting: stimulation of the chemoreceptor trigger zone. - Drowsiness: central nervous system depression. - Dry mouth: decreased salivary secretion. - Sweating: autonomic activation. - Itching: histamine release.

Serious or Rare Side Effects: - Respiratory depression: reduced drive to breathe. - Severe hypotension: marked drop in blood pressure. - Convulsions: seizure activity in susceptible individuals. - Dependence and withdrawal: physical and psychological reliance. - Anaphylaxis: rare severe allergic reaction. - adrenal insufficiency: impaired cortisol production.

When using Oramorph, careful assessment and monitoring are essential.

- Assess    :      "); - Assess  ");  ullet  \\